This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe
November 3–5, 2025
Vienna Congress and Convention Center, Vienna, AustriaNovember 11–12, 2025 | Digital Partnering

Han-Oh Park
Founder & CEO at siRNAgen Therapeutics
Speaker

Profile

1984 B.S., Chemistry at Seoul National University
1986 M.S., Chemistry at Korea Advanced Institute of Science and Technology (KAIST)
1992 Ph.D., Chemistry at Korea Advanced Institute of Science and Technology (KAIST)

1992-Present Founder, CEO & Chairman, BIONEER, Daejeon, Korea
2019-Present Founder & CEO, siRNAgen Therapeutics (Subsidiary of BIONEER), Daejeon, Korea

2001-Present Vice-President, Korea Biotechnology Industry Organization
2013-2014 Committee Member, Presidential Advisory Council on Science & Technology
2021-Present Member, The National Academy of Engineering of Korea
2022-Present Co-chair, Korean Society for Synthetic Biology
2023-Present President, Korea R&D Industry Association

2020 Citation for the Contribution of Health and Medical Technology Promotion, Minister of Health and Welfare, Korea
2021 Gold Tower Order of Industrial Service Merit, Government of Korea
2023 POSCO TJ Park Prize - 2023 Technology Prize Winner, POSCO TJ Park Foundation, Korea
2025 FACS Award for Distinguished Contribution to Economic Advancement, Federation of Asian Chemical Societies